Central aortic pressure augmentation in stable renal transplant recipients

Charles J Ferro1, Tessa Savage, Sarah J Pinder

  • 1The Richard Bright Kidney Unit, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, England, UK. charlesferro@hotmail.com

Kidney International
|June 26, 2002
PubMed

Insights

Cardiovascular risk in kidney transplant patients is high. A functioning arteriovenous fistula and cyclosporine immunosuppression increase aortic pressure augmentation, a key cardiovascular risk factor.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Cardiovascular disease is the leading cause of death in renal transplant recipients.
  • Classical risk factors underestimate cardiovascular risk in this population.
  • Arterial wave reflections are emerging as significant predictors of cardiovascular mortality.

Purpose of the Study:

  • To assess classical and non-classical risk factors for aortic pressure augmentation.
  • To investigate the contribution of these factors in stable renal transplant recipients.
  • To identify potential modifiable risk factors for cardiovascular events.

Main Methods:

  • Non-invasive pulse wave analysis was used.
  • Radial artery waveforms were recorded in 250 stable renal transplant recipients.
  • Central aortic waveforms and augmentation index were calculated.

Main Results:

  • Female sex, higher heart rate, mean arterial pressure, and age correlated with increased aortic augmentation.
  • Persistence of an arteriovenous fistula and longer time on renal replacement therapy were significant correlates.
  • Cyclosporine immunosuppression was associated with a higher aortic augmentation index.

Conclusions:

  • Arteriovenous fistula presence and cyclosporine treatment are associated with increased aortic augmentation.
  • These factors may be reversible contributors to high cardiovascular risk in renal transplant recipients.
  • Further research into managing these factors could mitigate cardiovascular mortality.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...